Tagged with MEA

UAE Georg Schroeckenfuchs, Novartis’ president for the Middle East and head of MEA cluster, is a 32-year veteran of the pharmaceutical industry and describes the company’s footprint within the MEA region, provides insights into its strategy of segmenting their markets into three categories. Furthermore, he discusses the company’s strategic priorities when…

UAE With nearly 240 years of history behind it, Takeda continues to position itself as a leading global R&D-driven biopharmaceutical organization. Dr Mahender Nayak, recently appointed area head of India, the CIS countries, Middle East, Turkey, and Africa (ICMEA), explains the company’s strategic presence in the region and outlines his strategy…

UAE The UAE’s distinctive willingness to embrace innovation and the ‘can-do’ spirit of authorities marks the country out as worthy of attention as an initial product launch platform.   “Along with fellow GCC members, Kuwait and Saudi Arabia, the UAE is notable for its accelerated regulatory pathways. Due to these mechanisms,…

UAE As Fujifilm, the iconic Japanese photography and imaging company, continues to expand into healthcare, it is betting heavily on the Middle East and Africa (MEA). Chihiro Sasaki, healthcare division manager in the region, explains the company’s footprint in MEA, its efforts to help the region combat chronic diseases through innovative…

UAE The Pharmaceutical Research and Manufacturers Association Gulf (PHRMAG) represents the region’s leading innovative biopharmaceutical research companies. Dream Samir, secretary general of the organization, discusses PHRMAG’s efforts to continue impacting the region’s pharmaceutical industry, the priorities of the private sector and why the UAE is well positioned to compete on the…

UAE With the corporate objective of having 75 percent of the company’s revenue coming from international markets by 2020, Laboratoires Expanscience is betting on the Middle East and Africa region. Frédéric Le Moigne, managing director for the MEA region, explains the main challenges presented by the political instability affecting the region,…

UAE AKI Investments, under the Alphamed brand, is one of the leading distributors and service providers for the healthcare industry in the Middle East. Doaa Albarbari, COO for AKI’s pharma and consumer business, explains how the company has shied away from being simple “box movers” to become the partner of choice…

UAE From Turkey to Tajikistan, Bangladesh to Bahrain, and Russia to Rwanda, multinational pharma firms are increasingly situating wide-ranging management responsibilities in the UAE. The following is an inexhaustive list of some of the widely varying geographies being managed from the UAE, as well as insights from the executives overseeing them.…

UAE Genpharm is a Dubai-based regional company providing market access and marketing solutions for rare disease products in the MENA region. Co-Founders Karim Smaira and Kamel Ghammachi provide insights into the rare disease space in the region, explain how the company is positioning itself in the gene therapy arena and why…

UAE Mediclinic Middle East, the largest private healthcare group in the UAE, is betting on the continuum of care to continue thriving in a highly competitive market. CEO David Hadley explains the company’s presence in the country, with seven hospitals and 21 clinics, and provides insights into the UAE healthcare industry’s…

UAE Eli Lilly’s president and general manager for the SAMETA (South Asia, Middle East, Turkey, and Africa) region, José Antonio Alas, discusses the challenges attached to overseeing 70 countries and half of the world’s population, the main opportunities for Lilly’s diabetes and oncology portfolio in the region, and the importance of…

UAE Mundipharma, through its model of independent associated companies, is aiming to take the lead in the Middle East, Turkey & Africa markets through its continuous commitment to improving peoples’ lives. Ashraf Allam, regional VP for the META region, discusses his journey of building Mundipharma’s strong footprint in the region and…